JPWO2021049633A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021049633A5 JPWO2021049633A5 JP2021545626A JP2021545626A JPWO2021049633A5 JP WO2021049633 A5 JPWO2021049633 A5 JP WO2021049633A5 JP 2021545626 A JP2021545626 A JP 2021545626A JP 2021545626 A JP2021545626 A JP 2021545626A JP WO2021049633 A5 JPWO2021049633 A5 JP WO2021049633A5
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- mutation
- group
- secretion
- cyclophilin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019165583 | 2019-09-11 | ||
| PCT/JP2020/034538 WO2021049633A1 (ja) | 2019-09-11 | 2020-09-11 | 難治性遺伝性腎疾患アルポート症候群の根治療法のための薬剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2021049633A1 JPWO2021049633A1 (https=) | 2021-03-18 |
| JPWO2021049633A5 true JPWO2021049633A5 (https=) | 2023-09-20 |
Family
ID=74865760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021545626A Pending JPWO2021049633A1 (https=) | 2019-09-11 | 2020-09-11 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230082311A1 (https=) |
| EP (1) | EP4029514A4 (https=) |
| JP (1) | JPWO2021049633A1 (https=) |
| CN (1) | CN114761033A (https=) |
| WO (1) | WO2021049633A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113981000B (zh) * | 2021-08-24 | 2023-04-25 | 四川大学华西医院 | 一种COL4A3 p.P408H基因点突变小鼠模型及其构建方法、应用和试剂盒 |
| JP2024541719A (ja) * | 2021-11-18 | 2024-11-11 | レゾナンス ヘルス アナリシス サービシーズ ピーティーワイ リミテッド | シクロフィリンｄ関連疾患の処置方法 |
| CN117720619B (zh) * | 2023-05-16 | 2024-10-29 | 杭州禾泰健宇生物科技有限公司 | 一种多肽、抗光老化多肽及其应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009018179A2 (en) | 2007-07-27 | 2009-02-05 | Columbia University | Cyclophilin d-amyloid beta interaction potentiates mitochondrial dysfunction in a transgenic mouse model of alzheimer's disease |
| US20140050728A1 (en) * | 2011-01-28 | 2014-02-20 | Board Of Regents Of The University Of Nebraska | Methods and compositions for inhibiting cyclophilin d for the treatment and prevention of obesity and kidney indications |
| US9132138B2 (en) | 2012-08-27 | 2015-09-15 | Casi Pharmaceuticals, Inc. | Method for the treatment of multiple sclerosis |
| US9833467B2 (en) | 2012-12-12 | 2017-12-05 | University Of Rochester | Use of cyclophilin D inhibitors to treat or prevent bone disorders |
| EP3131569B1 (en) | 2014-04-16 | 2020-05-27 | Philippe Rouet | Apoo for use in a method for treating cancer and various pathophysiological situations |
| EP3164148A4 (en) | 2014-06-25 | 2017-12-13 | Cold Spring Harbor Laboratory | Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (emt) in cancer cells |
| WO2016014781A1 (en) * | 2014-07-25 | 2016-01-28 | Rgdi3, Inc. | Collagen iv replacement |
| US9738615B2 (en) | 2014-09-11 | 2017-08-22 | The University Of Kansas | Cyclophilin D inhibitors |
| JP2016124821A (ja) | 2014-12-26 | 2016-07-11 | 学校法人東京医科大学 | 敗血症性脳症用医薬 |
| US9914755B2 (en) * | 2015-01-08 | 2018-03-13 | Allergan, Inc. | Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized |
| US10179161B2 (en) | 2016-02-22 | 2019-01-15 | The University Of Rochester | Compositions and methods for enhancing cardiac function in the neonate |
| JP6990369B2 (ja) * | 2017-05-19 | 2022-02-03 | 国立大学法人 熊本大学 | 遺伝性腎疾患アルポート症候群治療薬に係る評価系 |
| CN112469433A (zh) | 2018-03-05 | 2021-03-09 | 得克萨斯农业及机械体系综合大学 | 作为免疫抑制剂和神经保护剂的gracilin A和同源物 |
-
2020
- 2020-09-11 EP EP20863506.0A patent/EP4029514A4/en not_active Withdrawn
- 2020-09-11 CN CN202080064429.0A patent/CN114761033A/zh active Pending
- 2020-09-11 WO PCT/JP2020/034538 patent/WO2021049633A1/ja not_active Ceased
- 2020-09-11 JP JP2021545626A patent/JPWO2021049633A1/ja active Pending
- 2020-09-11 US US17/642,612 patent/US20230082311A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6619741B2 (ja) | タンパク質凝集の阻害剤としてのヘテロアリールアミド | |
| JPWO2021049633A5 (https=) | ||
| EP3022206B1 (en) | Epha4 inhibitors as neuroprotective agents | |
| JP7285599B2 (ja) | 筋萎縮性側索硬化症治療剤及び治療用組成物 | |
| JP7699592B2 (ja) | グリシン輸送阻害剤を用いて骨髄性プロトポルフィリン症、ｘ連鎖プロトポルフィリン症または先天性赤血球生成性ポルフィリン症を処置する方法 | |
| US11497748B2 (en) | Method for activating AMPK and the use of adenine | |
| CN106687115B (zh) | 预防和/或治疗尿失禁的药物组合物 | |
| US20150336904A1 (en) | Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels | |
| KR20210102208A (ko) | 신경계 질환의 치료 | |
| TW487573B (en) | Pharmaceutical compositions for reducing ocular pressure | |
| CN101316584A (zh) | 用于预防及治疗由血管通透性亢进引起的眼病的医药 | |
| US20080262071A1 (en) | Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder | |
| US20250228827A1 (en) | Methods of treating erythropoietic protoporphyria, x-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors | |
| WO2024179420A1 (zh) | Lys01或其盐在制备Kir4.1钾离子通道抑制剂中的应用 | |
| EP4608403A1 (en) | Modulators and uses thereof | |
| JP2025518700A (ja) | グリシン輸送阻害剤を用いて肝性ポルフィリン症を処置するための組成物および方法 | |
| HK40108227A (zh) | 用甘氨酸转运蛋白抑制剂治疗红细胞生成性原卟啉病、x连锁原卟啉病或先天性红细胞生成性卟啉病的方法 | |
| CN104739812A (zh) | 含白藜芦醇的药物组合物及其应用 | |
| JP2022012379A (ja) | ユビキチン－プロテアソーム系の活性化剤、およびその利用 | |
| HK40094968B (zh) | 治疗红细胞生成性原卟啉病、x连锁原卟啉病或先天性红细胞生成性卟啉病的方法 | |
| JP2014533266A (ja) | 制御不能なタンパク質凝集を低下させるための薬剤としてのフッ素含有５−［２−（ピリド−３−イル）−エチル］−２，３，４−テトラヒドロ−１Ｈ−ピリド［４，３−ｂ］インドール |